Merck and co inc: Green light from the FDA in prostate cancer

Merck and co inc: Green light from the FDA in prostate cancer

(News Bulletin 247) – AstraZeneca and Merck announced that the United States Food & Drug Administration (FDA) has approved Lynparza…
Merck and co inc: Green light from the FDA in prostate cancer

Pfizer: Positive Results in Bacterial Infections

(News Bulletin 247) – Pfizer announced yesterday evening positive results from a phase 3 program evaluating the efficacy, safety and…
Merck and co inc: Green light from the FDA in prostate cancer

Costco wholesale: Same-store sales up 3.3% in May

(News Bulletin 247) – Costco Wholesale reported yesterday evening a 3.3% increase in its like-for-like sales in May, a disappointing…
Merck and co inc: Green light from the FDA in prostate cancer

Apple: Jefferies raises its price target before WWDC

(News Bulletin 247) – Jefferies announced on Friday that it had raised its price target on Apple from $195 to…
Market: Stocks in the green ahead of US jobs report

Market: Stocks in the green ahead of US jobs report

by Claude Chendjou PARIS (Reuters) – Wall Street is expected to rise and European stock markets are moving in the…
Merck and co inc: Green light from the FDA in prostate cancer

Nestlé: New plant-based drinks for baristas

(News Bulletin 247) – Nestlé announced on Friday that it had strengthened its plant-based drinks offer with the launch of…
Cac 40: The specter of a default on the American debt evaporates, the stock market takes off

Cac 40: The specter of a default on the American debt evaporates, the stock market takes off

(News Bulletin 247) – The CAC 40 rose sharply in mid-session on Friday, reassured by the approval of the Senate…
Merck and co inc: Green light from the FDA in prostate cancer

Logitech: Credit Suisse raises its price target

(News Bulletin 247) – Credit Suisse maintains its ‘neutral’ rating on Logitech, with a price target raised from 52 to…
Merck and co inc: Green light from the FDA in prostate cancer

Crossject: Appointment to the Supervisory Board

(News Bulletin 247) – Crossject announced on Friday the entry into its supervisory board of Daniel Teper, a pharmaceutical industry…
Merck and co inc: Green light from the FDA in prostate cancer

Mercialys: Oddo BHF reduces its price target

(News Bulletin 247) – Oddo BHF maintains its ‘neutral’ opinion on Mercialys, while lowering its target price from 10.2 to…